AI assistant
Sending…
REPLIGEN CORP — Director's Dealing 2019
Jul 18, 2019
30826_dirs_2019-07-17_251cd02e-f174-44c5-8a75-bc2cf6680827.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: REPLIGEN CORP (RGEN)
CIK: 0000730272
Period of Report: 2019-07-15
Reporting Person: Snodgres Jon (Chief Financial Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-07-15 | Common Stock | F | 295 | $85.95 | Disposed | 28239 | Direct |
Footnotes
F1: Payment of tax liability made via forfeiture of 295 shares of Common Stock valued at a price of $85.95 per share on July 15, 2019.
More from REPLIGEN CORP
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 27
Annual Report
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Proxy Solicitation & Information Statement
2026
Apr 2
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 23
Director's Dealing
2026
Mar 23